Acerus Pharma has acquired 1 company, including 1 in the last 5 years.
Acerus Pharma’s largest acquisition to date was in 2022, when it acquired Serenity Pharmaceuticals for $6M. Acerus Pharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
7025 Langer Drive Suite 205,
Mississauga, Ontario
L5N 0E8
Canada,
(416) 679-0771
www.aceruspharma.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2022-02-28 |
Serenity · Life Science
Milford, Pennsylvania · www.serenitypharma.com Serenity is a specialty pharmaceutical company focused on developing therapies for diseases associated with voiding disorders. Serenity is working to develop patented pharmaceuticals with unique delivery mechanisms and formulations, to provide safe and effective treatments for voiding disorders. Serenity was founded in 2006 and is based in Milford, Pennsylvania. |
6 | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
